Terminus vs Adept AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Terminus

GrowthRevenue Intelligence

Account-Based Marketing

Terminus is an ABM platform providing account intelligence, multi-channel advertising, chat, and email experiences to engage buying teams throughout the revenue cycle.

About

Terminus is an account-based marketing platform that provides B2B revenue teams with a multi-channel engagement suite spanning account-targeted advertising, personalized website experiences, account-based chat, and email signature marketing — all anchored to a shared account intelligence layer that integrates with CRM and marketing automation systems. The platform's account hub aggregates intent signals, CRM stage data, engagement history, and contact-level activity into unified account views that give sales and marketing teams shared context on where each target account stands in the buying journey. This unified account view enables coordinated, channel-consistent go-to-market motions rather than disconnected department-level campaigns that reach the same buyer with conflicting messages.

Full profile

Adept AI

EmergingAI Infra

AI Agents

Adept AI raised $415M to pioneer computer-use AI agents; its core research and agent team moved to Amazon in 2024 in a landmark talent acquisition while the company continues developing ACT-1 for enterprise automation.

About

Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and executing multi-step workflows in any application. Its ACT-1 model demonstrated the ability to control web browsers and desktop applications through natural language instructions, pioneering the computer-use agent paradigm that Anthropic later commercialized with Claude's computer use feature.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.